These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 2723538)

  • 21. Time course-changes in phosphatidylcholine profile during oxidative modification of low-density lipoprotein.
    Sasabe N; Keyamura Y; Obama T; Inoue N; Masuko Y; Igarashi Y; Aiuchi T; Kato R; Yamaguchi T; Kuwata H; Iwamoto S; Miyazaki A; Hara S; Yoshikawa T; Itabe H
    Lipids Health Dis; 2014 Mar; 13():48. PubMed ID: 24625108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A2.
    Kramer RM; Jakubowski JA; Deykin D
    Biochim Biophys Acta; 1988 Apr; 959(3):269-79. PubMed ID: 3355850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL.
    Tsoukatos DC; Arborati M; Liapikos T; Clay KL; Murphy RC; Chapman MJ; Ninio E
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3505-12. PubMed ID: 9437199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transfer of phospholipase A-resistant pyrene-dialkyl-glycerophosphocholine to plasma lipoproteins: differences between Lp[a] and LDL.
    Gorges R; Hofer G; Sommer A; Stütz H; Grillhofer H; Kostner GM; Paltauf F; Hermetter A
    J Lipid Res; 1995 Feb; 36(2):251-9. PubMed ID: 7751812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human plasma platelet-activating factor acetylhydrolase. Purification and properties.
    Stafforini DM; Prescott SM; McIntyre TM
    J Biol Chem; 1987 Mar; 262(9):4223-30. PubMed ID: 3558407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification and characterization of bovine brain platelet-activating factor acetylhydrolase.
    Hattori M; Arai H; Inoue K
    J Biol Chem; 1993 Sep; 268(25):18748-53. PubMed ID: 8360169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The degradation of platelet-activating factor in the plasma of a patient with familial high density lipoprotein deficiency (Tangier disease).
    Pritchard PH; Chonn A; Yeung CC
    Blood; 1985 Dec; 66(6):1476-8. PubMed ID: 4063532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of PAF-acetylhydrolase activity in human plasma low-density lipoprotein subfractions.
    Karabina SA; Liapikos TA; Grekas G; Goudevenos J; Tselepis AD
    Biochim Biophys Acta; 1994 Jun; 1213(1):34-8. PubMed ID: 8011677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein.
    Stafforini DM; Tjoelker LW; McCormick SP; Vaitkus D; McIntyre TM; Gray PW; Young SG; Prescott SM
    J Biol Chem; 1999 Mar; 274(11):7018-24. PubMed ID: 10066756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phospholipids with a short acyl chain modulate phospholipase and acyltransferase activities.
    Koumanov KS; Momchilova-Pankova AB; Markovska TT; Quinn PJ; Wolf C
    J Lipid Mediat Cell Signal; 1995 Jul; 12(1):59-76. PubMed ID: 7551690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydrolysis and transesterification of platelet-activating factor by lecithin-cholesterol acyltransferase.
    Liu M; Subbaiah PV
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6035-9. PubMed ID: 8016111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated.
    Liapikos TA; Antonopoulou S; Karabina SP; Tsoukatos DC; Demopoulos CA; Tselepis AD
    Biochim Biophys Acta; 1994 Jun; 1212(3):353-60. PubMed ID: 8199206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PAF-acether-degrading acetylhydrolase in plasma LDL is inactivated by copper- and cell-mediated oxidation.
    Dentan C; Lesnik P; Chapman MJ; Ninio E
    Arterioscler Thromb; 1994 Mar; 14(3):353-60. PubMed ID: 8123638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions.
    Häkkinen T; Luoma JS; Hiltunen MO; Macphee CH; Milliner KJ; Patel L; Rice SQ; Tew DG; Karkola K; Ylä-Herttuala S
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2909-17. PubMed ID: 10591668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.
    Stafforini DM; McIntyre TM; Carter ME; Prescott SM
    J Biol Chem; 1987 Mar; 262(9):4215-22. PubMed ID: 3549727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation.
    Hanasaki K; Yamada K; Yamamoto S; Ishimoto Y; Saiga A; Ono T; Ikeda M; Notoya M; Kamitani S; Arita H
    J Biol Chem; 2002 Aug; 277(32):29116-24. PubMed ID: 12021277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines.
    Marathe GK; Davies SS; Harrison KA; Silva AR; Murphy RC; Castro-Faria-Neto H; Prescott SM; Zimmerman GA; McIntyre TM
    J Biol Chem; 1999 Oct; 274(40):28395-404. PubMed ID: 10497200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression, purification and characterization of a human serine-dependent phospholipase A2 with high specificity for oxidized phospholipids and platelet activating factor.
    Rice SQ; Southan C; Boyd HF; Terrett JA; MacPhee CH; Moores K; Gloger IS; Tew DG
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1309-15. PubMed ID: 9494101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-activating factor (PAF) stimulates the production of PAF acetylhydrolase by the human hepatoma cell line, HepG2.
    Satoh K; Imaizumi T; Kawamura Y; Yoshida H; Hiramoto M; Takamatsu S; Takamatsu M
    J Clin Invest; 1991 Feb; 87(2):476-81. PubMed ID: 1846878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility.
    McCall MR; La Belle M; Forte TM; Krauss RM; Takanami Y; Tribble DL
    Biochim Biophys Acta; 1999 Jan; 1437(1):23-36. PubMed ID: 9931415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.